Considering the important role that the renin–angiotensin–aldosterone system plays in the pathogenesis of hypertension, current guidelines recommend angiotensin-converting enzyme inhibitors (ACEIs) or sartans (ARBs) as the first line of treatment in this disease in most patients if there are no contraindications [9]. The gene discussed is REN; the disease is Hypertension.